NCT03348449View on ClinicalTrials.gov

Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

June 29, 2018

Conditions
ComorbiditiesHIV/AIDS
Interventions
OTHER

Collection of data

Outcome of patients will be collected from charts to evaluate primary and secondary objectives

Trial Locations (1)

28034

Ramon y Cajal Hospital, Madrid

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Asociacion para el Estudio de las Enfermedades Infecciosas

NETWORK

NCT03348449 - Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi) | Biotech Hunter | Biotech Hunter